Volume 1 Issue 2
Diagnostic Accuracy of Pancreatic Cystic Lesions Evaluated by Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology
Michele K. McElroy, MD, Sarah Miller, BS, Douglas O. Faigel, MD, Terry K. Morgan, MD, PhD
Cystic lesions of the pancreas are a heterogenous group of entities ranging from non-neoplastic to malignant. Once thought to be rare, pancreatic cysts have proven to be relatively common with current imaging techniques.
Henoch-Schönlein Purpura and Ulcerative Colitis: Comorbidity or Coincidence?
Christoph K. Thoeringer*, Katja Specht, Roland M. Schmid, Wolfgang Huber
The burden of Crohn’s disease and ulcerative colitis is substantially increased by extraintestinal manifestations (EIMs). In addition to EIMs, there is very rare occurrence of autoimmunopathies like Henoch-Schönlein purpura (HSP) in inflammatory bowel disease. HSP is an inflammatory disease damaging small vessels by immune complex depositions, and affects the skin, joint, kidneys and gastrointestinal tract, especially in children.
Esophageal varices are considered to be the most common complication in patients with portal hypertension. Endoscopic ultrasonography (EUS) not only visualizes the surface of the varices but also provides detailed information about their internal structure. The direction of blood flow can be determined and its velocity measured only via endoscopic color Doppler ultrasonography (ECDUS), which can show graphically esophageal varices, paraesophageal veins, and passageways. It is important to evaluate the hemodynamics of the portal venous system when treating the esophageal varices of patients with portal hypertension and ECDUS and EUS are useful modalities for the evaluation of the detailed hemodynamics of esophageal varices.
Belladonna Alkaloid/Phenobarbital (Donnatal™) Effective for Treating IBS Symptoms
Ralph R. Turner*, Catherine Rahilly-Tierney, Donna Cowan, Richard Scranton, David Peura
Irritable bowel syndrome (IBS), characterized by abdominal discomfort, bloating, and abnormal defecation in the absence of any detectable organic cause, has a 10-15% prevalence in the U.S., accounting for up to $1.6 billion in direct costs and $19.2 billion in indirect costs.